Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics
Endocrinology and Metabolism · 28.02.2026 · 41 (1) · 57-85
DOI: 10.3803/enm.2025.2656 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 28.02.2026. Verfasst von Thanh T Nguyen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea. Hauptthemen laut MEDLINE: Sarcopenia, Aging, Muscle, Skeletal. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Sarcopenia is a progressive, age-related condition characterized by the loss of skeletal muscle mass, strength, and function, which increases the risk of falls, frailty, and loss of independence. Despite growing recognition and its incorporation into geriatric assessments, there is still no approved pharmacological treatment. This review provides an updated overview of sarcopenia, encompassing diagnostic criteria, biological mechanisms, and emerging therapeutic strategies. Key molecular features include mitochondrial dysfunction, nicotinamide adenine dinucleotide (NAD⁺) decline, fiber-type alterations, and dysregulation of myokines. Recent singlecell and multi-omics studies have revealed the heterogeneity of muscle tissue and distinct cell-type-specific aging patterns. Therapeutic efforts are evolving beyond lifestyle interventions toward targeted approaches, including myostatin inhibitors, NAD⁺ boosters, senolytics, and microbiome modulators. However, clinical translation remains constrained by heterogeneity in trial design and the absence of standardized outcome measures. Future sarcopenia care will likely involve precision medicine guided by biomarkers and supported by digital monitoring tools. Progressing from molecular discovery to clinical application will be essential for preserving muscle health and function in aging populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea.
- Center of Endocrinology, Metabolism, Genetic/Genomics and Molecular Therapy, Vietnam National Children's Hospital, Hanoi, Vietnam.
- Department of Hematology, Vietnam National Children's Hospital, Hanoi, Vietnam.
- School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea.
- Department of Microbiology, Wonkwang University School of Medicine, Iksan, Korea.
- Sarcopenia Total Solution Center, Wonkwang University, Iksan, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korea Health Industry Development Institute
- Ministry of Education
- Ministry of Health and Welfare
Zitieren
APA
Nguyen, T. T., Dao, T., Nguyen, H. T., Park, J. H., Jeong, S. J., Kim, S., Jo, Y., Thieu, N. T. H., Zhao, J., Ding, F., Yu, Y., Dung, V. C., Gariani, K., Kim, B. J., & Ryu, D. (2026). Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics. Endocrinology and Metabolism, 41(1), 57-85. https://doi.org/10.3803/enm.2025.2656
Vancouver
Nguyen TT, Dao T, Nguyen HT, Park JH, Jeong SJ, Kim S, et al. Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics. Endocrinology and Metabolism. 2026;41(1):57-85. doi:10.3803/enm.2025.2656
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thanh T and Dao, Tam and Nguyen, Ha Thu and Park, Jun-Hyeon and Jeong, Seung-Jun and Kim, Sei and Jo, Yunju and Thieu, Nhung T H and Zhao, Jiangqi and Ding, Fuan and Yu, Ying and Dung, Vu Chi and Gariani, Karim and Kim, Beom-Jun and Ryu, Dongryeol},
title = {Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics},
journal = {Endocrinology and Metabolism},
year = {2026},
volume = {41},
number = {1},
pages = {57--85},
doi = {10.3803/enm.2025.2656}
}
EUVIMED